Mostrar el registro sencillo del ítem
Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study
dc.contributor.author | Cueto-Sánchez, Alejandro | |
dc.contributor.author | Niu, Hao | |
dc.contributor.author | Del Campo-Herrera, Enrique | |
dc.contributor.author | Robles-Díaz, María Mercedes | |
dc.contributor.author | Sanabria-Cabrera, Judith Adriana | |
dc.contributor.author | Ortega-Alonso, Aida | |
dc.contributor.author | García-Cortés, Miren | |
dc.contributor.author | González-Grande, Rocío | |
dc.contributor.author | Jiménez-Pérez, Miguel | |
dc.contributor.author | Ruiz-Cabello, Francisco | |
dc.contributor.author | Andrade-Bellido, Raúl Jesús | |
dc.contributor.author | Lucena-González, María Isabel | |
dc.date.accessioned | 2021-12-21T13:04:19Z | |
dc.date.available | 2021-12-21T13:04:19Z | |
dc.date.created | 2021-12-21 | |
dc.date.issued | 2021-09-20 | |
dc.identifier.citation | Cueto-Sanchez A, Niu H, Del Campo-Herrera E, Robles-Díaz M, Sanabria-Cabrera J, Ortega-Alonso A, Garcia-Cortes M, Gonzalez-Grande R, Jimenez-Perez M, Ruiz-Cabello F, Andrade RJ, Lucena MI, Stephens C. Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study. Clin Pharmacol Ther. 2021 Dec;110(6):1604-1612. doi: 10.1002/cpt.2423. | es_ES |
dc.identifier.uri | https://hdl.handle.net/10630/23504 | |
dc.description.abstract | The identification of specific HLA risk alleles in drug-induced liver injury (DILI) points toward an important role of the adaptive immune system in DILI development. In this study, we aimed to corroborate the role of an adaptive immune response in DILI through immunophenotyping of leukocyte populations and immune checkpoint expressions. Blood samples were collected from adjudicated DILI (n = 12), acute viral hepatitis (VH; n = 13), acute autoimmune hepatitis (AIH; n = 9), and acute liver injury of unknown etiology (n = 15) at day 1 (recognition), day 7, and day >30. Blood samples from patients with nonalcoholic fatty liver disease (NAFLD; n = 20) and healthy liver controls (HLCs; n = 54) were extracted at one time point. Leukocyte populations and immune checkpoint expressions were determined based on cell surface receptors, except for CTLA-4 that was determined intracellularly, using flow cytometry. At recognition, DILI demonstrated significantly higher levels of activated helper T-cell (P < 0.0001), activated cytotoxic T-cells (P = 0.0003), Th1 (P = 0.0358), intracellular CTLA-4 level in helper T-cells (P = 0.0192), and PD-L1 presenting monocytes (P = 0.0452) than HLC. These levels approached those of HLC over time. No significant differences were found between DILI and VH. However, DILI presented higher level of activated helper T-cells and CTLA-4 than NAFLD and lower PD-L1 level than AIH. Our findings suggest that an adaptive immune response is involved in DILI in which activated CD4+ and CD8+ play an important role. Increased expression of negative immune checkpoints is likely the effect of peripheral tolerance regulation. | es_ES |
dc.description.sponsorship | The present study has been supported by grants of Instituto de Salud Carlos III cofounded by Fondo Europeo de Desarrollo Regional – FEDER (contract numbers: PI19/00883, PI16/01748, P18-RT-3364-2020, and PT20/000127). CIBERehd and Plataforma ISCiii Ensayos Clínicos are funded by Instituto de Salud Carlos III. Funding for open access charge: Universidad de Málaga/CBUA. The funding sources had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report, or in the decision to submit the manuscript for publication. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Wiley | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Hígado -- Enfermedades | es_ES |
dc.subject | Inmunoterapia | es_ES |
dc.subject.other | Lesión hepática inducida por fármacos | es_ES |
dc.subject.other | DILI | es_ES |
dc.subject.other | Sistema inmune | es_ES |
dc.subject.other | Inmunofenotipificación | es_ES |
dc.title | Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.centro | Facultad de Medicina | es_ES |
dc.identifier.doi | 10.1002/cpt.2423 | |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es_ES |